MedTrace Logo

TolerUp Enteral Feeding Protocol

NCT03648255 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2020-11-03

No results posted yet for this study

Summary

This prospective, observational, multi-center study will follow children with cerebral palsy who decided to switch to an enteral product that contains partially hydrolyzed protein and medium chain triglycerides as a result of clinical symptoms/diagnosis of gastrointestinal intolerance.

Conditions

  • Gastrointestinal Tolerance

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Aysugül Alptekin, MD · Abbott Turkey

Eligibility

Min Age
1 Year
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-19
Primary Completion
2020-07-20
Completion
2020-07-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03648255 on ClinicalTrials.gov